Tryptophan hydroxylase-2 (TPH2) is the rate-limiting enzyme in raphe serotonin biosynthesis, and polymorphisms of TPH2 are implicated in vulnerability to psychiatric disorders. Dynamic transcription regulation of TPH2 may underlie differences in vulnerability. We identified a transcription element in the TPH2 promoter that resembles the binding motif for RE-1 silencer of transcription (REST; also known as NRSF) transcription factor. REST limits tissue expression of non-neuronal genes through a canonical 21-bp motif called the NRSE (neuron-restrictive silencing element). The NRSE in TPH2 is a novel bipartite variant interrupted by a 6-base insertion. We confirmed that this bipartite NRSE permits transcriptional repression by REST identical to canonical NRSE in rat C6-glioma cells. Synthetic permutations of the motif revealed considerable flexibility in the juxtaposition of the two halves of bipartite NRSE. Computational analysis revealed many bipartite NRSE variants conserved between mouse and human genomes. A subgroup of these was found to bind REST by chromatin immunoprecipitation. Messenger RNAs for TPH2 and potassium channel H6, another gene with a bipartite NRSE, were up-regulated by dominant-negative REST in C6-glioma cells. These findings, which indicate that TPH2 expression is part of the developmental program regulated by REST and suggest that many previously unrecognized genes may be regulated by REST through the novel motif, have implications for the mechanism of REST action.Serotonin levels are regulated by the rate-limiting enzyme tryptophan hydroxylase, of which a neuronal isoform (NCBI Entrez Gene ID: TPH2) 3 was recently identified (1). TPH2 gene expression in the brain is restricted to raphe neurons, and TPH2 is likely the gene coding for the majority of tryptophan hydroxylase in these cells (1, 2). Serotonin modulates a variety of complex behaviors (3), and its signaling is implicated in the mechanism for a subset of antidepressants (4), but its precise role in mood regulation is unclear. A number of manipulations, including restriction of the essential dietary precursor tryptophan (5), stimulant drugs of abuse (6), or adverse developmental experiences (7), result in low brain serotonin levels and may underlie associated depression or anxiety phenotypes. Functional variants of TPH2 in mice are associated with decreased brain serotonin levels (8), and a TPH2 polymorphism in humans arguably (9) confers vulnerability to major depression (10). Associations with TPH2 polymorphisms are also reported for suicide (11), obsessivecompulsive disorder (12), and attention deficit disorder (13)(14)(15).In contrast to the growing number of genetic association studies, little is known about the regulation of TPH2 expression. Limited studies suggest that TPH2 mRNA levels are decreased following stress corticosteroids (16), unchanged (16) or increased by ovarian steroids (17), and increased by hypotensive stress (18) and one recent report suggests that POU3F2 may regulate TPH2 through a functional single-nucleoti...